2Ryan EA, lines S, Wallace C. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes [ J ]. Diabetes Care,2004,27 : 1028 - 1032.
3McFarlane SI, Chaiken RL, Hirsch S, el al. Near-normoglycaemic remission in Mrican-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell fuction [ J ]. Diabetes Med, 2001,18 : 10 - 16.
4UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ( UKPDS 33 ) [ J]. Lancet, 1998,352:837 - 853.
5UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes ( UKPDS 34 ) [ J ]. Lancet, 1998,352 : 854 - 865.
6American Diabetes Association. Standards of medical care in diabetes-2006 ( Position Statement ) [ J ]. Diabetes Care, 2006, 29 ( Suppl 1) : S4 - S42.
7Li YB, Xu W, Liao ZH, et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function.Diabetes Care, 2004, 27:2597-2602.
8.
9Brange J, Owens DR, Kang S, et al.Monomeric insulins and their experimental and clinical implications.Diabetes Care, 1990, 13:923-954.
10Home PD, Barriocanal L, Lindholm A, et al.Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in health volunteers.Eur J Clin Pharmacol, 1999, 55:199-203.
